Aortic Aneurysm Market Size & Growth Forecast 2027–2036, By Segments (Type, Treatment, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Aortic Aneurysm Market size was around USD 5.6 billion in 2026 and is slated to grow at a 11.97% CAGR from 2027 to 2036, crossing USD 17.35 billion by 2036. The industry revenue for 2027 is estimated at USD 6.16 billion.
Get more details on this report
Request Free Sample ReportAortic Aneurysm Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 48.76% of the market in 2026, supported by established vascular care pathways, advanced diagnostic imaging, strong hospital infrastructure, and high procedural adoption for aneurysm management.
- Asia Pacific is projected to grow at an 11.76% CAGR as expanding hospital capabilities, improved vascular diagnosis, minimally invasive procedures, and broader access to specialist care accelerate treatment adoption.
Segment Momentum
- Abdominal Aortic Aneurysm (AAA) held a 61.38% share in 2026 due to established screening pathways, consistent diagnosis, and well-defined treatment practices that support steady clinical management and intervention volumes.
- EVAR is the fastest-growing treatment and held a 57.47% share in 2026 because clinicians increasingly prefer minimally invasive procedures that improve treatment accessibility and fit modern vascular care pathways.
Market Expansion Drivers
- Increasing prevalence of aortic aneurysms driven by aging population and cardiovascular risk factors.
- Growth of minimally invasive EVAR and TEVAR procedures improving patient outcomes.
- Expansion of national screening programs enabling early aneurysm detection and treatment.
Leading Market Participants
- Prominent players in the aortic aneurysm market include Medtronic plc (Ireland), W. L. Gore & Associates, Inc. (United States), Cook Medical LLC (United States), Boston Scientific Corporation (United States), Endologix LLC (United States), MicroPort Scientific Corporation (China), Artivion, Inc. (United States), Lombard Medical Technologies GmbH (Germany), Braile Biomédica S.A. (Brazil), Cordis Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.6 billion
- 2027 Estimated Market Size: USD 6.16 billion.
- Projected Market Size: USD 17.35 billion by 2036
- Growth Forecast: 11.97% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Abdominal Aortic Aneurysm (AAA) (Type) | Endovascular Aneurysm Repair (EVAR) (Treatment) | Stent Grafts (Product) | Hospitals (End-use)
- Emerging Opportunity Segment: Thoracic Aortic Aneurysm (TAA) (Type) | Endovascular Aneurysm Repair (EVAR) (Treatment) | Catheters (Product) | Ambulatory Surgery Centers (End-use)
Market Growth Drivers and Industry Trends
Increasing prevalence of aortic aneurysms driven by aging population and cardiovascular risk factors
An aging population and the increasing burden of cardiovascular risk factors are contributing to a larger patient pool requiring diagnosis and management, thereby supporting the aortic aneurysm market. The risk of developing aortic aneurysms increases with age and is influenced by conditions and behaviors associated with vascular deterioration, including hypertension, smoking, and other cardiovascular disorders. As healthcare systems manage growing numbers of older adults and patients with vascular risk factors, demand is increasing for diagnostic imaging, surveillance, medical management, and interventions for aneurysmal disease. Greater awareness of vascular health and improved access to diagnostic procedures are also helping identify patients who require continued monitoring of aneurysm progression.
Growth of minimally invasive EVAR and TEVAR procedures improving patient outcomes
Advances in endovascular treatment are expanding therapeutic options for patients who may require repair, with EVAR and TEVAR supporting the growth of the aortic aneurysm market through less invasive approaches. These procedures use catheter-based techniques to place endovascular grafts within affected portions of the aorta, reducing the need for extensive open surgical access in appropriate patients. Their adoption is being supported by improvements in graft design, delivery systems, imaging guidance, and procedural expertise, while reduced surgical trauma and shorter recovery requirements can make endovascular approaches attractive for selected patients. Continued refinement of these techniques is also broadening their applicability across different aneurysm anatomies and clinical circumstances.
Expansion of national screening programs enabling early aneurysm detection and treatment
The development and expansion of organized screening initiatives are improving opportunities to identify aortic aneurysms before serious complications occur, strengthening the aortic aneurysm market through earlier diagnosis and intervention. Screening can help detect asymptomatic aneurysms in populations considered at elevated risk, allowing healthcare professionals to establish surveillance schedules and assess whether medical management or procedural treatment is appropriate. Wider use of ultrasound and other imaging technologies can facilitate structured assessment within preventive healthcare pathways, while increased awareness among clinicians and eligible populations can improve participation in screening programs. Earlier recognition also enables patients to receive risk-factor management and regular monitoring before aneurysm progression creates an urgent clinical situation.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of aortic aneurysms driven by aging population and cardiovascular risk factors | 2.40% | High | North America, Europe | High | Near Term |
| Growth of minimally invasive EVAR and TEVAR procedures improving patient outcomes | 2.10% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Expansion of national screening programs enabling early aneurysm detection and treatment | 1.80% | High | Europe, North America | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The aortic aneurysm market was led by North America, which held a 48.76% share in 2026. The region's strong position is supported by advanced cardiovascular healthcare infrastructure, widespread access to diagnostic imaging, and increasing emphasis on early detection and intervention for vascular disorders. Greater awareness of cardiovascular health and the availability of specialized treatment pathways contribute to the diagnosis and management of aortic aneurysms. The use of sophisticated imaging and minimally invasive treatment approaches is also strengthening clinical capabilities, while established healthcare systems support the adoption of advanced endovascular and surgical procedures. An aging population and the growing focus on managing chronic cardiovascular conditions further contribute to sustained demand for diagnosis, monitoring, and treatment solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by improving healthcare infrastructure, expanding access to specialized cardiovascular services, and rising awareness of vascular diseases. Growing healthcare investment is enabling hospitals and medical centers to strengthen diagnostic and interventional capabilities, including the use of advanced imaging and minimally invasive techniques. Increasing urbanization and greater access to specialized care are also improving the detection and management of aortic aneurysms. At the same time, demographic aging and the expanding burden of cardiovascular conditions are encouraging healthcare providers to enhance vascular disease screening and treatment capacity. These factors are supporting wider adoption of advanced approaches for diagnosis, monitoring, and intervention across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Vascular CareGermany prioritizes evidence-based vascular treatment pathways and specialized cardiovascular centers for aortic aneurysm management. Demand in Germany is supported by the adoption of advanced stent graft systems and continued focus on improving treatment efficiency for aging patient populations.
France 🇫🇷
Structured Screening FocusFrance emphasizes coordinated screening and referral pathways to identify aneurysm cases earlier and optimize treatment planning. French healthcare institutions continue to adopt less invasive repair techniques while strengthening multidisciplinary vascular care services.
Italy 🇮🇹
Specialized Surgical NetworksItaly's aortic aneurysm market relies on established vascular surgery centers that manage complex aneurysm cases and support device adoption. In Italy, clinicians are increasingly balancing conventional surgery with endovascular procedures to improve patient recovery and resource utilization.
Japan 🇯🇵
Aging Population ManagementJapan's aortic aneurysm market is influenced by a large elderly population requiring long-term monitoring and intervention. Healthcare providers in Japan increasingly favor minimally invasive repair approaches and routine imaging surveillance to reduce complications associated with aneurysm progression.
South Korea 🇰🇷
Technology-Enabled InterventionSouth Korea is integrating advanced imaging and catheter-based procedures into aortic aneurysm treatment strategies. The market in South Korea benefits from strong tertiary care infrastructure and growing use of sophisticated endovascular devices in major cardiovascular centers.
United States 🇺🇸
Advanced Endovascular AdoptionThe U.S. aortic aneurysm market is shaped by widespread use of endovascular repair technologies and increasing emphasis on surveillance programs for high-risk patients. Hospitals in the U.S. continue investing in minimally invasive devices and imaging-guided interventions to improve procedural outcomes.
Segment Leadership and Growth Trends
Aortic Aneurysm Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Abdominal Aortic Aneurysm (AAA) (Largest Segment) vs Thoracic Aortic Aneurysm (TAA) (Fastest-Growing Segment)
Abdominal aortic aneurysm (AAA) dominated the aortic aneurysm market with a 61.38% share in 2026. Its leading position is associated with the substantial clinical burden of aneurysmal disease affecting the abdominal aorta and the need for timely diagnosis and intervention to reduce the risk of rupture and related complications. Increasing awareness of vascular health, greater use of diagnostic imaging, and improvements in screening and disease detection are supporting identification of abdominal aneurysms. The availability of established treatment pathways also contributes to sustained demand for management of AAA.
Thoracic aortic aneurysm (TAA) is the fastest-growing type as advances in cardiovascular imaging are improving the detection and characterization of aneurysms affecting the thoracic aorta. Greater clinical attention to early identification of vascular abnormalities is supporting diagnosis among patients who may previously have remained undetected. Improvements in minimally invasive interventions and growing adoption of specialized cardiovascular care are also creating opportunities for more effective management of thoracic aneurysms.
Treatment Segment Analysis: Endovascular Aneurysm Repair (EVAR) (Largest & Fastest-Growing Segment)
Endovascular aneurysm repair (EVAR) led the aortic aneurysm market and was also the fastest-growing treatment segment, accounting for a 57.47% share in 2026. EVAR has gained strong adoption because it offers a minimally invasive alternative to conventional open surgical approaches for eligible patients, potentially supporting shorter recovery periods and reduced procedural burden. Continued improvements in endovascular devices, imaging guidance, and procedural techniques are expanding the applicability of this approach. Increasing preference for less invasive interventions in vascular care, together with growing clinical emphasis on effective aneurysm management, is strengthening demand for EVAR.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA) | Abdominal Aortic Aneurysm (AAA) | Thoracic Aortic Aneurysm (TAA) |
| Treatment | Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR) | Endovascular Aneurysm Repair (EVAR) | Endovascular Aneurysm Repair (EVAR) |
| Product | Stent Grafts, Catheters | Stent Grafts | Catheters |
| End-use | Hospitals, Ambulatory Surgery Centers, Clinics | Hospitals | Ambulatory Surgery Centers |
Competitive Landscape and Market Positioning
Leading companies in the aortic aneurysm market:
1. Medtronic plc (Ireland)
2. W. L. Gore & Associates Inc. (United States)
3. Cook Medical LLC (United States)
4. Boston Scientific Corporation (United States)
5. Endologix LLC (United States)
6. MicroPort Scientific Corporation (China)
7. Artivion Inc. (United States)
8. Lombard Medical Technologies GmbH (Germany)
9. Braile Biomédica S.A. (Brazil)
10. Cordis Corporation (United States)
In the aortic aneurysm market, innovation is focused on improving diagnostic precision and treatment effectiveness. Collaborative clinical research initiatives are supporting the development of advanced therapeutic approaches. New solution introductions are enhancing procedural outcomes, while continuous technological improvements are strengthening patient care standards in the aortic aneurysm market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| W. L. Gore & Associates Inc. (United States) | |||||||
| Cook Medical LLC (United States) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Endologix LLC (United States) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| Artivion Inc. (United States) | |||||||
| Lombard Medical Technologies GmbH (Germany) | |||||||
| Braile Biomédica S.A. (Brazil) | |||||||
| Cordis Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Nectero | Apr-26 | Nectero, supported by Boston Scientific, reported positive mid-stage clinical results for its EAST System (PGG therapy), showing slowed abdominal aortic aneurysm growth in 90% of patients over two years. The ongoing Phase II/III trial is critical for validating the device’s disease-modifying potential in managing AAA, representing a significant shift toward pharmaceutical-like intervention in vascular surgery. |
| W. L. Gore & Associates | Jul-25 | W. L. Gore & Associates secured CE Mark approval for its lower-profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis. Compatibility with 6 Fr sheaths enhances the device's utility as a bridging stent for complex FEVAR and BEVAR procedures, supporting improved procedural efficiency and technical flexibility in endovascular aneurysm repair. |
| Vivasure Medical | Jun-25 | Vivasure Medical received approval for its PerQseal Elite, a fully bioresorbable, sutureless vascular closure device. The system allows for streamlined large-bore closure in interventions including EVAR, potentially reducing complications and enhancing procedural safety during minimally invasive cardiovascular surgeries across European markets. |
| Bentley | Nov-24 | Bentley announced the first-in-human implantation of its BeFlared bridging stent graft system. This clinical milestone validates the device's design, which aims to improve aortic aneurysm repair by offering enhanced graft support and deployment precision, directly addressing technical challenges associated with treating complex vascular anatomies. |
| Endoron Medical | Jul-24 | Endoron Medical secured $10 million in Series A funding led by Sofinnova Partners to accelerate the clinical validation of its Aortoseal catheter-based endostapling system. The capital supports early feasibility studies and development aimed at improving fixation technology in endovascular abdominal aortic aneurysm repair, addressing critical durability requirements for complex aortic procedures. |
| Terumo Aortic | Jul-24 | Terumo Aortic successfully completed the first commercial implantation of its Fenestrated TREO device in Asia. This milestone marks a significant geographic expansion for the company’s advanced endovascular aneurysm repair (EVAR) portfolio, strengthening its competitive positioning in high-growth regional markets requiring sophisticated solutions for complex aortic anatomies. |
| Shape Memory Medical | Mar-24 | Shape Memory Medical closed a $38 million Series C financing round to scale its proprietary shape memory polymer-based embolic technology. The investment supports the commercial expansion of its endovascular embolisation portfolio, targeting improved clinical outcomes for vascular conditions, including complex aortic aneurysms, by leveraging advanced material science in minimally invasive repair. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Aortic Aneurysm Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Severity | Small / Low-Risk Aneurysms, Moderate / Expanding Aneurysms, Large / High-Risk Aneurysms, Ruptured Aneurysms |
| Procedure Urgency | Elective Procedures, Urgent Procedures, Emergency Procedures |
| Patient Age Group | Under 50 Years, 50–64 Years, 65–74 Years, 75 Years and Above |
Aortic Aneurysm Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Patient Screening and Early Detection Opportunities |
|
| Minimally Invasive Treatment Adoption Assessment |
|
| Reimbursement and Access Landscape Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much is the aortic aneurysm market worth?
How is the aortic aneurysm industry expected to grow over the next 10 years?
How are aging-related risk factors and expanding screening practices shaping demand in the aortic aneurysm market?
How is the shift toward minimally invasive EVAR and TEVAR procedures influencing treatment adoption patterns?
Why does Abdominal Aortic Aneurysm (AAA) dominate the aortic aneurysm market?
Why is Endovascular Aneurysm Repair (EVAR) the fastest-growing treatment in the aortic aneurysm market?
Why does North America lead the aortic aneurysm market?
Why is Asia Pacific the fastest-growing region in the aortic aneurysm market?
What are the key competitors in the aortic aneurysm landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization